VIPR1 and neoplasm: Fourth, the focus and conclusions of the current study are orthogonal to previous studies that examined the suppression of autoimmunity by native VIP, or studies that examined the activity of VIP-R antagonists as tumor cytostatic drugs14,15,61,62.